[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343472-105":59,"doc-detail-343472-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epidermal-growth-factor-receptor-egfr-and-vascular-endothelial-growth-factor-a-vegf-a-expressions-in-ethiopian-female-breast-cancer-and-their-association-with-histopathologic-features","Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features","","Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) are key regulators of breast tumor progression, including invasion, metastasis, patient survival, and drug resistance. The study evaluates EGFR and VEGF-A protein expression and examines their associations with hormone receptor status and histopathologic characteristics in invasive female breast cancer among Ethiopian patients. Primary tumor tissues from 85 cases undergoing modified radical mastectomy were analyzed by immunohistochemistry and correlated with histopathologic features.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epidermal-growth-factor-receptor-egfr-and-vascular-endothelial-growth-factor-a-vegf-a-expressions-in-ethiopian-female-breast-cancer-and-their-association-with-histopathologic-features/343472/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epidermal-growth-factor-receptor-egfr-and-vascular-endothelial-growth-factor-a-vegf-a-expressions-in-ethiopian-female-breast-cancer-and-their-association-with-histopathologic-features/343472.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the aim of the study regarding EGFR and VEGF-A?","Question",{"text":112,"@type":113},"To assess EGFR and VEGF-A protein expression status and evaluate their association with hormone receptor status and histopathologic characteristics in invasive female breast cancer among Ethiopians.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were EGFR and VEGF-A expressions measured?",{"text":117,"@type":113},"Primary breast tumor tissues from 85 invasive breast cancer cases were analyzed for EGFR and VEGF protein expressions using immunohistochemical techniques on FFPE blocks.",{"name":119,"@type":110,"acceptedAnswer":120},"What relationships were observed between EGFR/VEGF-A and receptor or clinical features?",{"text":121,"@type":113},"EGFR over-expression was observed in 22% of samples, and EGFR showed a significant inverse correlation with estrogen receptor (ER) and progesterone receptor (PR) statuses, while EGFR and VEGF expressions did not show significant association with tumor size, grade, lymph node status, or age at diagnosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343472,1790751440,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","PLOS ONE  \nOPEN ACCESS  \nCitation: Addisu S, Bekele A, Seifu D, Assefa M, Gemechu T, Hoenerhoff MJ, et al. (2024)  \nEpidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features. PLoS ONE 19(10): e0308411 . [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.1371/journal.pone](10.1371/journal.pone).0308411  \nEditor: Daniele Ugo Tari, Local Health Authority Caserta: Azienda Sanitaria Locale Caserta, ITALY  \nReceived: July 25, 2023  \nAccepted: July 22, 2024  \nPublished: October 15, 2024  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal.pone.030841](https://doi.org/10.1371/journal.pone.030841)1  \nCopyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.  \nData Availability Statement: All relevant data are within the manuscript.  \nRESEARCH ARTICLE  \nEpidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features  \nSisay Addisu1 *, Abebe Bekele2¤, Daniel Seifu1¤, Mathewos Assefa3, Tufa Gemechu4, Mark J. Hoenerhoff5, Sofia D. Merajver6  \n1 Department of Biochemistry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia, 2 Department of Surgery, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia, 3 Department of Internal Medicine, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia, 4 Department of Pathology, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia, 5 In Vivo Animal Core, Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, United States of America, 6 Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States of America  \n¤ Current address: School of Medicine, University of Global Health Equity, Kigali, Rwanda  \n* [sisay.addisu@aau.edu.et](sisay.addisu@aau.edu.et)  \nAbstract  \nBackground  \nEpidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGF) play important role in breast tumor growth, invasion, metastasis, patient survival and drug resistance. The aim of this study was to evaluate the protein expression status of EGFR and VEGF-A, as well as their association with hormone receptor status and histopathological characteristics in the invasive type of female breast cancer among Ethiopians.  \nMethod  \nThe primary breast tumor tissues were obtained from 85 Ethiopian invasive breast cancer cases that underwent modified radical mastectomy (MRM) from June 2014 to June 2015. Their FFPE blocks were analyzed for EGFR and VEGF protein expressions using immunohistochemical techniques. The expressions were also correlated with histopathologic features.  \nResult  \nEpidermal growth factor receptor over-expression was observed in 22% of the tumor samples. VEGF-A expression was negative in 13.41%, low in 63 .41%, moderate in 20 .73%, and high in 2.44% . EGFR expression, but not VEGF-A, showed a significant inverse correlation with both estrogen receptor (ER) (P = 0.01) and progesterone receptor (PR) statuses (P =  \nFunding: This work is funded in part by Addis Ababa University and International Reproductive Health Training (CIRHT) program at the University of Michigan.","cbCaimX4SSzqS5ah","https://ap.wps.com/l/cbCaimX4SSzqS5ah","pdf",494112,14,"English","# Abstract\n## Background\n## Method\n## Result\n## Conclusion\n# Introduction","[{\"question\":\"What is the aim of the study regarding EGFR and VEGF-A?\",\"answer\":\"To assess EGFR and VEGF-A protein expression status and evaluate their association with hormone receptor status and histopathologic characteristics in invasive female breast cancer among Ethiopians.\"},{\"question\":\"How were EGFR and VEGF-A expressions measured?\",\"answer\":\"Primary breast tumor tissues from 85 invasive breast cancer cases were analyzed for EGFR and VEGF protein expressions using immunohistochemical techniques on FFPE blocks.\"},{\"question\":\"What relationships were observed between EGFR/VEGF-A and receptor or clinical features?\",\"answer\":\"EGFR over-expression was observed in 22% of samples, and EGFR showed a significant inverse correlation with estrogen receptor (ER) and progesterone receptor (PR) statuses, while EGFR and VEGF expressions did not show significant association with tumor size, grade, lymph node status, or age at diagnosis.\"}]","Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor A (VEGF-A) expressions in Ethiopian female breast cancer and their association with histopathologic features | PDF",1790051260,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/043105e14bffe8bfc038fbbd34a4d207.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b43cc99bb17e3591b98e180a192568fc.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88a0ca874f1dac21dc47441353223a39.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4f945991d42edfd33c6b80ebd8698c0.webp",980,1268]